EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Prognostic Role of Beta‐2 Microglobulin in Diffuse Large B‐Cell Lymphoma: Systematic Review and Meta‐Analysis of Observational Studies

Hamideh Feiz Disfani iD, Mahsan Ramezani iD, Milad Moradi iD, Mostafa Kamandi iD, Molood Foogerdi iD, Vajiheh Sadat Saghi iD, Rasoul Shavaleh iD, Kazem Rahmani iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70416 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Reports, 2025. Verfasst von Hamideh Feiz Disfani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, beta 2-Microglobulin, Biomarkers, Tumor. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence indicates that beta‐2 microglobulin (β2M) plays a prognostic role in patients with diffuse large B‐cell lymphoma (DLBCL).

Aim

However, due to controversies among previous studies, this meta‐analysis was conducted to evaluate the prognostic role of β2M in DLBCL patients. Methods and Results Relevant studies were identified through a systematic search using specific keywords in PubMed/Medline, Scopus, and Web of Science databases. Studies that provided complete information on the hazard ratio with a 95% confidence interval for β2M with respect to overall survival (OS) and progression‐free survival (PFS) in multivariate models were included in the meta‐analysis. A total of 30 studies, encompassing 25 128 patients, were included in this meta‐analysis. The pooled analysis demonstrated a significant association between elevated β2M levels and poor OS in DLBCL patients (HR Pooled : 1.65, 95% CI: 1.45–1.88, p ‐value < 0.01). Similarly, increased β2M levels were significantly associated with lower PFS in DLBCL patients (HR Pooled : 1.54, 95% CI: 1.39–1.70, p ‐value < 0.01).

Conclusion

The available evidence suggests that β2M serves as an independent prognostic marker with significant effects on OS and PFS in DLBCL patients. Elevated serum β2M levels are associated with poor prognosis and worse OS and PFS outcomes in DLBCL patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, Diffusebeta 2-MicroglobulinBiomarkers, TumorHumansPrognosisObservational Studies as TopicAntineoplastic Combined Chemotherapy ProtocolsProgression-Free Survival

Stichwörter der Autor:innen

DLBCLbeta‐2 microglobulinnon‐Hodgkin's lymphomaprognosis

Substanzen

beta 2-MicroglobulinBiomarkers, TumorB2M protein, human

Autor:innen und Institutionen

  • Department of Emergency Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Emergency Medicine, School of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Iran.
  • Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Hematologist-Oncologist, Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Emergency Medicine, Faculty of Medicine, Birgand University of Medical Sciences, Birjand, Iran.

ORCID-Profile: Hamideh Feiz Disfani, Mahsan Ramezani, Milad Moradi, Mostafa Kamandi, Molood Foogerdi, Vajiheh Sadat Saghi, Rasoul Shavaleh, Kazem Rahmani

Zitieren

APA

Disfani, H. F., Ramezani, M., Moradi, M., Kamandi, M., Foogerdi, M., Saghi, V. S., Shavaleh, R., & Rahmani, K. (2025). Prognostic Role of Beta‐2 Microglobulin in Diffuse Large B‐Cell Lymphoma: Systematic Review and Meta‐Analysis of Observational Studies. Cancer Reports. https://doi.org/10.1002/cnr2.70416

Vancouver

Disfani HF, Ramezani M, Moradi M, Kamandi M, Foogerdi M, Saghi VS, et al. Prognostic Role of Beta‐2 Microglobulin in Diffuse Large B‐Cell Lymphoma: Systematic Review and Meta‐Analysis of Observational Studies. Cancer Reports. 2025. doi:10.1002/cnr2.70416

BibTeX
@article{Disfani2025,
  author = {Disfani, Hamideh Feiz and Ramezani, Mahsan and Moradi, Milad and Kamandi, Mostafa and Foogerdi, Molood and Saghi, Vajiheh Sadat and Shavaleh, Rasoul and Rahmani, Kazem},
  title = {Prognostic Role of Beta‐2 Microglobulin in Diffuse Large B‐Cell Lymphoma: Systematic Review and Meta‐Analysis of Observational Studies},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70416}
}
Kostenlos starten →